Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
scPharmaceuticals Inc
SCPH | US
4.42
USD-0.11
-2.43%
SCPH | US
About scPharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/10/2024
Close
4.42
Open
4.51
High
4.58
Low
4.34
scPharmaceuticals Inc. a pharmaceutical company engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services Inc. for development of single use SmartDose device. The company was incorporated in 2013 and is headquartered in Burlington Massachusetts.
View LessSCPH | US
Risk
58.0
Sharpe
-0.52
Luna's Score
43/100
Recommendation
Sell
Luna says (SCPH | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Strong Revenue Growth (> 10%)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
46.7%1 month
58.0%3 months
61.0%6 months
69.7%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
24.50
Debt to equity
4.47
Debt to assets
0.63
Ent. to EBITDA
-6.69
Ent. to rev.
9.54
PEG
-
Other Fundamentals
EBITDA
-60.36M
MarketCap
221.13M
MarketCap(USD)
221.13M
Div. yield
-
Op. margin
-179.18
Erngs. growth
-
Rev. growth
391.70
Ret. on equity
-166.89
Short ratio
13.61
Short perc.
9.51
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.77
Range1M
1.42
Range3M
1.84
Volumes: Market Activity
Rel. volume
0.54
Price X volume
714.53K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -6.69 | - | Cheaper |
| Ent. to Revenue | 9.54 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 24.50 | 15.55 | Expensive |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 61.00 | - | Par |
| Debt to Equity | 4.47 | -1.23 | Expensive |
| Debt to Assets | 0.63 | 0.25 | Expensive |
| Market Cap | 221.13M | - | Emerging |
